JP2023545372A5 - - Google Patents
Info
- Publication number
- JP2023545372A5 JP2023545372A5 JP2023518752A JP2023518752A JP2023545372A5 JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5 JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089135P | 2020-10-08 | 2020-10-08 | |
| US63/089,135 | 2020-10-08 | ||
| PCT/US2021/054171 WO2022076818A1 (en) | 2020-10-08 | 2021-10-08 | Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545372A JP2023545372A (ja) | 2023-10-30 |
| JPWO2022076818A5 JPWO2022076818A5 (https=) | 2024-10-15 |
| JP2023545372A5 true JP2023545372A5 (https=) | 2024-10-15 |
Family
ID=81126063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518752A Pending JP2023545372A (ja) | 2020-10-08 | 2021-10-08 | デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240024289A1 (https=) |
| EP (1) | EP4225305A4 (https=) |
| JP (1) | JP2023545372A (https=) |
| KR (1) | KR20230084186A (https=) |
| CN (1) | CN116615243A (https=) |
| AU (1) | AU2021356687A1 (https=) |
| CA (1) | CA3195133A1 (https=) |
| IL (1) | IL301971A (https=) |
| MX (1) | MX2023003993A (https=) |
| TW (1) | TW202228682A (https=) |
| WO (1) | WO2022076818A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102793584B1 (ko) | 2016-12-31 | 2025-04-09 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 불안의 치료를 위한 설하 덱스메데토미딘의 용도 |
| PL3813802T3 (pl) | 2018-06-27 | 2025-04-22 | Bioxcel Therapeutics, Inc. | Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania |
| EP3999058A4 (en) | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| DK2906213T3 (en) * | 2012-10-15 | 2018-02-19 | Orion Corp | VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY |
| CA2924190C (en) * | 2013-10-07 | 2019-07-09 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions |
| KR102793584B1 (ko) * | 2016-12-31 | 2025-04-09 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 불안의 치료를 위한 설하 덱스메데토미딘의 용도 |
| EP3999058A4 (en) * | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN |
-
2021
- 2021-10-08 EP EP21878615.0A patent/EP4225305A4/en not_active Withdrawn
- 2021-10-08 WO PCT/US2021/054171 patent/WO2022076818A1/en not_active Ceased
- 2021-10-08 CN CN202180069020.2A patent/CN116615243A/zh active Pending
- 2021-10-08 KR KR1020237013556A patent/KR20230084186A/ko not_active Withdrawn
- 2021-10-08 CA CA3195133A patent/CA3195133A1/en active Pending
- 2021-10-08 MX MX2023003993A patent/MX2023003993A/es unknown
- 2021-10-08 IL IL301971A patent/IL301971A/en unknown
- 2021-10-08 US US18/030,405 patent/US20240024289A1/en active Pending
- 2021-10-08 JP JP2023518752A patent/JP2023545372A/ja active Pending
- 2021-10-08 AU AU2021356687A patent/AU2021356687A1/en not_active Abandoned
- 2021-10-08 TW TW110137597A patent/TW202228682A/zh unknown